Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Targeting CD96 For Antibody Based Elimination Of Leukemic Stem Cells In AML: A New Strategy In Stem Cell Transplantation

Matthias Staudinger, PhD, Christian Kellner, PhD, Matthias Peipp, PhD, Natalie Schub, MD, Andreas Humpe, MD, Martin Gramatzki, MD

Blood (2013) 122 (21): 3972.

https://doi.org/10.1182/blood.V122.21.3972.3972

Published: 2013

Journal Articles

Selective Inhibition Of The PI3K-Alpha Isoform Blocks Myeloma Cell Growth and Survival

Andreas Guenther, MD, Renate Burger, PhD, Wolfram Klapper, Matthias Staudinger, PhD, Martin Gramatzki, MD

Blood (2013) 122 (21): 5364.

https://doi.org/10.1182/blood.V122.21.5364.5364

Published: 2013

Journal Articles

The CD317-Targeted Immunotoxin HM1.24-ETA′ Efficiently Eliminates Malignant Plasma Cells in Vitro and in Vivo

Matthias Staudinger, Pia Glorius, Christian Kellner, Andreas Guenther, Roland Repp, Renate Burger, Martin Gramatzki, Matthias Peipp

Blood (2012) 120 (21): 1838.

https://doi.org/10.1182/blood.V120.21.1838.1838

Published: 2012

Journal Articles

The JAK1/2 Inhibitor Ruxolitinib Kills Malignant Plasma Cells and Is Synergistic with PI3K and mToR Inhibitors

Renate Burger, Tim Bugdahn, Matthias Staudinger, Anna Lena Michaelis, Matthias Peipp, Andreas Guenther, Martin Gramatzki

Blood (2012) 120 (21): 1844.

https://doi.org/10.1182/blood.V120.21.1844.1844

Published: 2012

Journal Articles

Inhibitors of Mtor and PI3K Synergistically Block Plasmacytoma Cell Growth

Andreas Guenther, Renate Burger, Wolfram Klapper, MD, Matthias Staudinger, Kathrin Richter, Tanja Ahrens, Martin Gramatzki

Blood (2011) 118 (21): 2903.

https://doi.org/10.1182/blood.V118.21.2903.2903

Published: 2011

Journal Articles

Fusion Proteins of Ligands for NKG2D and CD20-Directed ScFvs Sensitize Lymphomas for NK Cell-Mediated Lysis

Christian Kellner, Daniela Hallack, Pia Glorius, Matthias Staudinger, Sahar Mohseni Nodehi, Tina Maurer, Roland Repp, Michel de Weers, Jan G.J. van De Winkel, Paul W.H.I. Parren, Andreas Humpe, Martin Gramatzki, Matthias Peipp

Blood (2010) 116 (21): 2843.

https://doi.org/10.1182/blood.V116.21.2843.2843

Published: 2010

Journal Articles

The Novel Bispecific Antibody [(CD20) 2 xCD16] Efficiently Triggers Lysis of Neoplastic B Cells

Pia Glorius, Anne Baerenwaldt, Christian Kellner, Matthias Staudinger, Paul W.H.I. Parren, Jan G. J. van De Winkel, Andreas Humpe, Thomas Valerius, Roland Repp, Falk Nimmerjahn, Martin Gramatzki, Matthias Peipp

Blood (2010) 116 (21): 2846.

https://doi.org/10.1182/blood.V116.21.2846.2846

Published: 2010

Journal Articles

The Novel JAK2 Inhibitor NVP-BSK805 Has Cytotoxic Activity on Malignant Plasma Cells

Renate Burger, PhD, Franziska Rademacher, Matthias Staudinger, PhD, Matthias Peipp, PhD, Andreas Güunther, MD, Martin Gramatzki, MD

Blood (2010) 116 (21): 2993.

https://doi.org/10.1182/blood.V116.21.2993.2993

Published: 2010

Journal Articles

Maturation of Monocyte-Derived Dendritic Cells Induced by Dual Targeting of Endocytosis Receptor and CD40

Matthias Staudinger, PhD, Inga Rebekka Catenhusen, Matthias Peipp, PhD, Christian Kellner, PhD, Roland Repp, MD, Martin Gramatzki, MD

Blood (2010) 116 (21): 4293.

https://doi.org/10.1182/blood.V116.21.4293.4293

Published: 2010

Journal Articles

The Immunotoxin HM1.24-ETA′ Is a Potent Inducer of Apoptosis in Malignant Plasma Cells

Matthias Staudinger, Anja Muskulus, Renate Burger, Andreas Guenther, Roland Repp, Martin Gramatzki, Matthias Peipp

Blood (2008) 112 (11): 3658.

https://doi.org/10.1182/blood.V112.11.3658.3658

Published: 2008

Journal Articles

Potent Activation of Healthy Donor T-Cells Specific for Mantle Cell Lymphoma Immunoglobulin Derived Peptides by CD40- and TLR7/8-Ligand Matured Dendritic Cells in Vitro

Liane Bergmann, Matthias Staudinger, PhD, Christiane Pott, MD, Ingrid Bolz, Martin Gramatzki, MD, Michael Kneba, MD, PhD, Benedikt Gahn, MD

Blood (2008) 112 (11): 3502.

https://doi.org/10.1182/blood.V112.11.3502.3502

Published: 2008

Journal Articles

Efficient Lysis of Myeloma Cells by CD16 Positive Effector Cells with Recombinant Single Chain Bispecific Antibodies Targeting HM1.24.

Matthias Peipp, PhD, Claudia Ehlert, Matthias Staudinger, PhD, Joerg Bruenke, PhD, Georg Fey, PhD, Martin Gramatzki, MD, Roland Repp, MD

Blood (2007) 110 (11): 2752.

https://doi.org/10.1182/blood.V110.11.2752.2752

Published: 2007

NARROW

Targeting CD96 For Antibody Based Elimination Of Leukemic Stem Cells In AML: A New Strategy In Stem Cell Transplantation

Selective Inhibition Of The PI3K-Alpha Isoform Blocks Myeloma Cell Growth and Survival

The CD317-Targeted Immunotoxin HM1.24-ETA′ Efficiently Eliminates Malignant Plasma Cells in Vitro and in Vivo

The JAK1/2 Inhibitor Ruxolitinib Kills Malignant Plasma Cells and Is Synergistic with PI3K and mToR Inhibitors

Inhibitors of Mtor and PI3K Synergistically Block Plasmacytoma Cell Growth

Fusion Proteins of Ligands for NKG2D and CD20-Directed ScFvs Sensitize Lymphomas for NK Cell-Mediated Lysis

The Novel Bispecific Antibody [(CD20) 2 xCD16] Efficiently Triggers Lysis of Neoplastic B Cells

The Novel JAK2 Inhibitor NVP-BSK805 Has Cytotoxic Activity on Malignant Plasma Cells

Maturation of Monocyte-Derived Dendritic Cells Induced by Dual Targeting of Endocytosis Receptor and CD40

The Immunotoxin HM1.24-ETA′ Is a Potent Inducer of Apoptosis in Malignant Plasma Cells

Potent Activation of Healthy Donor T-Cells Specific for Mantle Cell Lymphoma Immunoglobulin Derived Peptides by CD40- and TLR7/8-Ligand Matured Dendritic Cells in Vitro

Efficient Lysis of Myeloma Cells by CD16 Positive Effector Cells with Recombinant Single Chain Bispecific Antibodies Targeting HM1.24.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only